35 related articles for article (PubMed ID: 6787839)
1. Empty sella in somatotropic pituitary adenomas; a series of 23 cases.
Sharifi G; Mohammadi E; Paraandavaji E; Tavangar SM; Dabbagh Ohadi MA; Jafari A; Jahanbakhshi A; Akbari Dilmaghani N; Davoudi Z; Smith TR; Banihashemi G; Azadi M; Hatami N; Zenonos GA; Mohajeri Tehrani M
Front Surg; 2024; 11():1350032. PubMed ID: 38500594
[TBL] [Abstract][Full Text] [Related]
2. Reply to the Letter to the Editor on "Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children".
Zhang J
Horm Metab Res; 2024 Jun; 56(6):472. PubMed ID: 38698580
[TBL] [Abstract][Full Text] [Related]
3. Development of an Empty Sella.
Chen Cardenas SM; Mukherjee D; Hamrahian AH
JCEM Case Rep; 2023 Jul; 1(4):luad091. PubMed ID: 37908993
[No Abstract] [Full Text] [Related]
4. Coexistent primary empty sella syndrome and hyperprolactinemia. Report of 11 cases.
Gharib H; Frey HM; Laws ER; Randall RV; Scheithauer BW
Arch Intern Med; 1983 Jul; 143(7):1383-6. PubMed ID: 6870411
[TBL] [Abstract][Full Text] [Related]
5. CSF circulation in subjects with the empty sella syndrome.
Brismar K; Bergstrand G
Neuroradiology; 1981; 21(4):167-75. PubMed ID: 7254514
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone secretion in empty sella syndrome.
Brismar K
J Endocrinol Invest; 1982; 5(6):417-22. PubMed ID: 6763056
[TBL] [Abstract][Full Text] [Related]
7. Empty sella syndrome associated with diabetes insipidus: case report and review of the literature.
Lambert M; Gaillard RC; Vallotton MB; Megret M; Delavelle J
J Endocrinol Invest; 1989 Jun; 12(6):433-7. PubMed ID: 2671113
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and pituitary tumors.
Silvestrini F; Liuzzi A; Chiodini PG
Curr Top Exp Endocrinol; 1978; 3():131-72. PubMed ID: 26521
[No Abstract] [Full Text] [Related]
10. The safety of bromocriptine in long-term use: a review of the literature.
Weil C
Curr Med Res Opin; 1986; 10(1):25-51. PubMed ID: 3516579
[TBL] [Abstract][Full Text] [Related]
11. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
Brismar K
Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
[TBL] [Abstract][Full Text] [Related]
12. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
Valensi P; Combes ME; Perret G; Attali JR
J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
[TBL] [Abstract][Full Text] [Related]
13. Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.
Celani MF; Giambuzzi G; Simoni M; Montanini V
J Endocrinol Invest; 1987 Aug; 10(4):421-5. PubMed ID: 3119699
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
